Publications

Changing bone patterns with progression of chronic kidney disease. Drüeke, Tilman B.; Massy, Ziad A.. Kidney International. 2016; 89: p.289-302. doi:10.1016/j.kint.2015.12.004
Article
Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin. Matignon, Marie; Leibler, Claire; Moranne, Olivier; Salomon, Laurent; Charron, Dominique; Lang, Philippe; Jacquelinet, Christian; Suberbielle, Caroline; Grimbert, Philippe. Clinical Transplantation. 2016; 30: p.731-740. doi:10.1111/ctr.12743
Article
The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods. Mariani, Laura; Stengel, Bénédicte; Combe, Christian; Massy, Ziad A.; Reichel, Helmut; Fliser, Danilo; Pecoits-Filho, Roberto; Lopes, Antonio A.; Yamagata, Kunihiro; Wada, Takashi; Wong, Michelle M. Y.; Speyer, Elodie; Port, Friedrich K.; Pisoni, Ronald L.; Robinson, Bruce M.. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation. 2016; 68: p.402-413. doi:10.1053/j.ajkd.2016.03.414
Article
Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology. Elbaz, A.. Rev Neurol (Paris).. 2016; 503-511: p.503-511
    Article
    Classification of autistic individuals and controls using cross-task characterization of fMRI activity. Chanel, Guillaume; Pichon, Swann; Conty, Laurence; Berthoz, Sylvie; Chevallier, Coralie; Grèzes, Julie. NeuroImage. Clinical. 2016; 78-88: p.78-88. doi:10.1016/j.nicl.2015.11.010
      Article
      Ethical issues in clinical trials involving older subjects: the right to participate in clinical trials and have access to care; the protection of vulnerable subjects and the issue of informed consent. Hirsch, Emmanuel; Weil-Dubuc, Paul-Loup. In: Cherubini, Antonio; Bernabei, Roberto; Ferrucci, Luigi; Marchionni, Niccolò; Studenski, Stephanie; Vellas, Bruno. Clinical trials in older adults. Chichester, UK: John Wiley & Sons, Ltd; 2016. p.p.45-59.
      Book section
      Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. Parfrey, Patrick S.; Block, Geoffrey A.; Correa-Rotter, Ricardo; Drüeke, Tilman B.; Floege, Jürgen; Herzog, Charles A.; London, Gerard M.; Mahaffey, Kenneth W.; Moe, Sharon M.; Wheeler, David C.; Chertow, Glenn M.. Clinical journal of the American Society of Nephrology: CJASN. 2016; 539-546: p.539-546. doi:10.2215/CJN.06370615
        Article
        Reconsidering the Lack of Urea Toxicity in Dialysis Patients. Massy, Ziad A.; Pietrement, Christine; Touré, Fatouma. Seminars in Dialysis. 2016; 333-337: p.333-337. doi:10.1111/sdi.12515
          Article
          Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block?. Ducreux, M.; Pignon, J. P.. Eur J Cancer. 2016; 178-179: p.178-179. doi:10.1016/j.ejca.2016.10.001 10.1016/j.ejca.2016.10.001. Epub 2016 Nov 10.

          Article
          Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer. McKeever, M. R.; Sio, T. T.; Gunn, G. B.; Holliday, E. B.; Blanchard, P.; Kies, M. S.; Weber, R. S.; Frank, S. J.. Chin Clin Oncol. 2016; 54: p.54. doi:10.21037/cco.2016.07.03 10.21037/cco.2016.07.03. Epub 2016 Aug 2.

          Article